Article Text

PDF
CASE REPORT
Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient
  1. E Costa1,
  2. J Buxton2,
  3. J Brown3,
  4. K E Templeton4,
  5. J Breuer3,
  6. I Johannessen1
  1. 1Royal Infirmary of Edinburgh, Edinburgh, UK
  2. 2Borders General Hospital, Melrose, UK
  3. 3Great Ormond St Hospital for Children, London, UK
  4. 4Department of Medical Virology, Royal Infirmary of Edinburgh, Edinburgh, UK
  1. Correspondence to KE Templeton, Kate.Templeton{at}nhslothian.scot.nhs.uk

Summary

A 79-year-old man with chronic lymphocytic leukaemia presented with fever and a widespread vesicular rash on 19 November 2014. The patient had not been under immunosuppressive regime for 6 months. He had received a shingles vaccine on 14th October and developed flu-like symptoms after 2 weeks. Intravenous antimicrobial therapy including aciclovir was started. He remained stable with no evidence of systemic involvement. On day 5, he developed respiratory and renal failure that required transfer to intensive care unit. Vesicle fluid, bronchoalveolar lavage and plasma were positive for varicella zoster virus by PCR. Slight clinical improvement allowed extubation on day 16. He subsequently deteriorated and died on day 25. Multiorgan failure was considered the immediate cause of death whereas disseminated varicella zoster infection was stated in the medical certificate as the other condition leading to this outcome. Varicella zoster Oka vaccine strain was detected in vesicle fluid, using PCR.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.